I like the new strategy - it makes sense, and I think there is still plenty of money to be made. The drug they just sold is worth $750m if all goes to plan (which is a huge deal), and they will earn future royalties off it if it makes it to market.
Hopefully the new strategy means PXS will be able to generate significant funds for drug development (as we have just seen with the latest drug sale) and at the same time bring a portfolio of drugs to market and earn a decent return on it. They are cashed up now, so hoping for some good progress.
PXS Price at posting:
22.7¢ Sentiment: Buy Disclosure: Held
